Literature DB >> 26573206

Rheumatic manifestations in inflammatory bowel diseases: a link between GI and rheumatology.

Rodolfo Perez-Alamino1, Hernan Maldonado-Ficco2, José A Maldonado-Cocco3.   

Abstract

Musculoskeletal symptoms are the most frequent extra-intestinal manifestations of inflammatory bowel disease (IBD), ranging between 10 and 40 % of cases. Pathogenesis is still unclear, although several factors have been associated (genetic, environmental, and immunologic pathways). Rheumatic manifestations in IBD patients are heterogeneous, including axial and peripheral involvement, dactylitis, enthesitis, uveitis, as well as skin involvement. Currently, magnetic resonance imaging and ultrasonography are important tools for detecting early pathological changes in IBD patients with suspected rheumatic disease. New advances into the genetics and pathophysiology have provided more effective and targeted therapy for IBD patients with rheumatic manifestations. Given the high prevalence, awareness of the musculoskeletal symptoms is essential to avoid a misdiagnosis. Finally, an interdisciplinary approach of IBD patients, including rheumatologist and gastroenterologist, will improve the quality of life these patients.

Entities:  

Keywords:  Axial involvement; Dactylitis; Enthesitis; Inflammatory back pain; Inflammatory bowel diseases; Peripheral arthritis; Sacroiliitis

Mesh:

Year:  2015        PMID: 26573206     DOI: 10.1007/s10067-015-3116-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  49 in total

1.  Peripheral arthritis in the course of inflammatory bowel diseases.

Authors:  Ilhami Yüksel; Hilmi Ataseven; Omer Başar; Seyfettin Köklü; Ibrahim Ertuğrul; Aysel Ulker; Ulkü Dağlı; Nurgül Saşmaz
Journal:  Dig Dis Sci       Date:  2010-05-11       Impact factor: 3.199

Review 2.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

3.  Development, sensibility, and reliability of the Toronto Axial Spondyloarthritis Questionnaire in inflammatory bowel disease.

Authors:  Khalid A Alnaqbi; Zahi Touma; Laura Passalent; Sindhu R Johnson; George A Tomlinson; Adele Carty; Robert D Inman
Journal:  J Rheumatol       Date:  2013-09-01       Impact factor: 4.666

4.  A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.

Authors:  Richard H Duerr; Kent D Taylor; Steven R Brant; John D Rioux; Mark S Silverberg; Mark J Daly; A Hillary Steinhart; Clara Abraham; Miguel Regueiro; Anne Griffiths; Themistocles Dassopoulos; Alain Bitton; Huiying Yang; Stephan Targan; Lisa Wu Datta; Emily O Kistner; L Philip Schumm; Annette T Lee; Peter K Gregersen; M Michael Barmada; Jerome I Rotter; Dan L Nicolae; Judy H Cho
Journal:  Science       Date:  2006-10-26       Impact factor: 47.728

Review 5.  Novel development in extraintestinal manifestations and spondylarthropathy.

Authors:  M De Vos; P Hindryckx; D Laukens
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-04       Impact factor: 3.043

6.  Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients.

Authors:  Maddalena Zippi; Claudia Corrado; Roberta Pica; Eleonora Veronica Avallone; Claudio Cassieri; Daniela De Nitto; Paolo Paoluzi; Piero Vernia
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

7.  Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association.

Authors:  K de Vlam; H Mielants; C Cuvelier; F De Keyser; E M Veys; M De Vos
Journal:  J Rheumatol       Date:  2000-12       Impact factor: 4.666

8.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; J Listing; N Akkoc; J Brandt; J Braun; C T Chou; E Collantes-Estevez; M Dougados; F Huang; J Gu; M A Khan; Y Kirazli; W P Maksymowych; H Mielants; I J Sørensen; S Ozgocmen; E Roussou; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2009-03-17       Impact factor: 19.103

9.  The prevalence of inflammatory sacroiliitis assessed on magnetic resonance imaging of inflammatory bowel disease: a retrospective study performed on 186 patients.

Authors:  S Leclerc-Jacob; G Lux; A C Rat; V Laurent; A Blum; I Chary-Valckenaere; L Peyrin-Biroulet; D Loeuille
Journal:  Aliment Pharmacol Ther       Date:  2014-03-04       Impact factor: 8.171

Review 10.  Extraintestinal manifestations and complications in inflammatory bowel disease: from shared genetics to shared biological pathways.

Authors:  Suzanne van Sommeren; Marcel Janse; Juha Karjalainen; Rudolf Fehrmann; Lude Franke; Jingyuan Fu; Rinse K Weersma
Journal:  Inflamm Bowel Dis       Date:  2014-06       Impact factor: 5.325

View more
  4 in total

1.  Joint involvement in Mexican patients with ulcerative colitis: a hospital-based retrospective study.

Authors:  Jesús K Yamamoto-Furusho; Andrea Sarmiento-Aguilar
Journal:  Clin Rheumatol       Date:  2017-09-15       Impact factor: 2.980

2.  Gastrointestinal comorbidities in patients with psoriatic arthritis.

Authors:  Ariel Zohar; Arnon Dov Cohen; Haim Bitterman; Ilan Feldhamer; Sari Greenberg-Dotan; Idit Lavi; Doron Comanesther; Erez Batat; Devy Zisman
Journal:  Clin Rheumatol       Date:  2016-08-17       Impact factor: 2.980

3.  Performance of Two Screening Questionnaires for Inflammatory Arthritis in Patients with Inflammatory Bowel Disease.

Authors:  Rubén Queiro; Sergio Rodríguez-Caminero; Sabino Riestra; Ruth de Francisco; Isabel Pérez-Martínez; Javier Ballina
Journal:  Biomed Res Int       Date:  2018-05-08       Impact factor: 3.411

4.  Rheumatic manifestations of inflammatory bowel diseases: A study from the Middle East.

Authors:  Mohammed Hammoudeh; Eman Elsayed; Saad Al-Kaabi; Manik Sharma; Mohamed Elbadri; Prem Chandra; Niveen Abu Nahia; Samer Hammoudeh
Journal:  J Int Med Res       Date:  2018-07-02       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.